click below
click below
Normal Size Small Size show me how
diabetes terms
| Question | Answer |
|---|---|
| continuous glucose monitoring system CGMS | device worn 72hrs. monitors glucose. data analyzed for glucose patterns to tailor treatment |
| continuous subq insulin infusion / insulin pump | device worn, delivers basal insulin. Pt can bolus before eating attempt mimic normal pancreatic fxn |
| diabetic mellitus | group of metabolic diseases characterized by HYPERglycemia resulting from defects in insulin secretion, action, or both |
| diabetic ketoacidosis DKA | metabolic derangement in type1, results from insulin deficiency. Acidic ketone bodies formed, resulting in acidosis. Requires hospitalization. Caused by non-adherence, illness, or infection |
| fasting plasma glucose FPG | blood glucose obtained after at least 8hr fast |
| gestational diabetes mellitus GDM | any degree of glucose intolerance with its onset during pregnancy |
| glycated hemoglobin glycosylated hemoblobin Hgb A OR A1C | long term measure of glucose control that is a result of glucose attaching to hemoglobin for the life of the red blood cell (120days) |
| Goal of diabetes therapy | normal to near normal level of glycated hemoglobin, the same as in the non-diabetic pt |
| hyperglycemia | elevated blood glucose level fasting >110 mg/dL 2hr postprandial >140mg/dL |
| hyperglycemic hyperosmolar nonketotic sysdrome HHNS | metabolic disorder of DM2 resulting from insulin deficiency and demand for insulin; assoc. w/ polyuria & severe dehydration |
| postprandial | following a meal |
| hypoglycemia | low blood glucose level <60mg/dL |
| impaired fasting glucose (IFG) impaired glucose tolerance (IGT) (risk factors for diabetes & CVD) | metabolic stage intermediate between normal glucose homeostasis and biabetes; now referred to as PREDIABETES |
| insulin | hormone secreted by the beta cells of the islets of Langerhans of the pancreas that is necessary for the metabolism of carbs, proteins, and fats; insulind deficiency results in DM |
| islet cell transplantation | investigational procedure, purified cadaver islet cells injected into the liver portal vein; hopes to secrete insulin and cure type1 diabeted |
| ketone | highly acidic substance formed when liver breaks down free fatty acids in absence of insulin; (byproduct of fat breakdown) resulting in diabetic ketoacidosis |
| medical nutrition therapy MNT | nutritional therapy prescribed for mgt of diabetes |
| nephropathy | lont term complication of diabetes. kidney cells damaged. early stages microalbuminuria, progressing to end stage renal disease |
| neuropathy | long term complication of diabetes resulting from damage to nerve cell |
| prediabetes | impaired glucose metabolism. betweeen normal and diabetic. included IFG / IGT (risk factors for DM & CVD) |
| retinopathy | long term complication of diabetes. ocular microvascular system damaged |
| self monitoring blood glucose SMBG | method of capillary blood glucose testing / finger stick |
| sulfonylurea | classification of oral antibiabetic med for type II DM. stimulates insulin secretion & action |
| thiazolidinedione | class of oral antidiabetic med reduces insulin resistance enhances insulin action w/out directly stimulating insulin secretion |
| type 1(I) DM (insulin dependent DM) (juvenile DM) | ABSENCE of insulin production/secretion from autoimmune destruction of beta cells of islets of langerhans in pancreas |
| type 2(II) DM (non-insulin dependent DM) (adult onset DM) | deficiency of insulin production decreased insulin action and increased insulin resistance |
| glycosuria | glucose in urine |
| metabolic syndrome 'prediabetes' 'syndrome x' | to overcome insulin resistance & prevent glucose buildup increased amounts of insulin secreted to maintain normal level |
| insulinemia | excessive insulin production |